138 strains of Acinetobacter baumannii clinical distribution and drug resistance.docVIP

 PAGE \* MERGEFORMAT 9 138 strains of Acinetobacter baumannii clinical distribution and drug resistance Of: Murray Qin, Zhu Jianfeng, Tang Lixia [Abstract] Objective Acinetobacter baumannii infection and drug resistance trends for the clinical treatment of Acinetobacter baumannii infection to provide evidence. Methods dilution method for drug susceptibility testing, and 138 strains of Acinetobacter baumannii drugs sensitivity tests were analyzed retrospectively. Results Distribution of Acinetobacter baumannii in sputum and bronchial aspirate, followed by a pus and discharge. departments distributed to ICU ward as the most, followed by respiratory medicine. pathogen resistance serious, gentamicin, amikacin, ciprofloxacin, ofloxacin, and sent La Xilin / tazobactam resistance rates were 88.41%, 81.16%, 76.81%, 63.04%, 73.91%. cefoperazone / sulbactam, meropenem, imipenem, imipenem resistance lower, respectively, 28.26%, 33.33%, 37.68%, 24.64%, and found eight full-resistant strains. Conclusion of Acinetobacter baumannii to antimicrobial drugs has produced multiple drug resistance, should pay attention to bacteria infection and drug resistance monitoring, to prevent the spread of multiple drug-resistant strains, prevention of nosocomial infection in order to guide the rational use of antibiotics. [Keywords:] Acinetobacter, drug resistance, bacteria, antibiotics, antimicrobial susceptibility test Acinetobacter baumannii non-fermenting Gram-negative bacteria, widely distributed in nature, are opportunistic pathogens. Bacterium is an important pathogen of nosocomial infection, mainly caused by respiratory infections, can also cause bacteremia, urinary tract infection, secondary meningitis, surgical site infections, ventilator-associated pneumonia. The resistance rate to commonly used antibiotics has gradually increased, and the clinicians and microbiologists causing serious concern. In order to understand Acinetobacter baumannii infection and drug resistance